Non-steroidal anti-inflammatory drugs in practice of cardiologist: choice of drug
https://doi.org/10.33667/2078-5631-2020-28-22-26
Abstract
Data from an original study evaluating the efficacy and safety of dexketoprofen in the conservative treatment of pain syndrome in patients are presented. This paper presents three clinical cases of successful conservative treatment of pain in patients. Patients, depending on the therapy they received, were divided into three groups: patient S., 50 years old, (pain in the joints) received Dexketoprofen-SZ at a dose of 25 mg twice a day for 5 days; a patient, 50 years old, (severe pain in the lumbosacral spine) received Dexketoprofen-SZ 25 mg every 8 hours (daily dose not more than 75 mg) for 5 days; the patient, 20 years old, (painful heavy periods) received Dexketoprofen-SZ, depending on the intensity of pain, 25 mg every 8 hours. Conclusions. The drug Dexketoprofen-SZ at a dosage of 25 mg 2–3 times a day has shown high efficacy and good tolerability in various patients in the practice of an outpatient cardiologist.
About the Author
M. Yu. Omelchenko
National Medical Research Centre n. a. V. A. Almazov
Russian Federation
Saint Petersburg
Russian Federation
Saint Petersburg
References
1. О. А. Лесная. Боль в практике врача: сложный феномен и непростые пути решения. Трудный пациент. 2019, № 3, т. 17, с. 21–25.
2. Tacconelli S, Bruno A, Grande R, et al. Nonsteroidal anti-inflammatory drugs and cardiovascular safety – translating pharmacological data into clinical readouts. Expert Opin Drug Saf. 2017 Jul; 16 (7): 791–807.
3. Я. И. Ашихмин, О. М. Драпкина. Лечение болевого синдрома с позиции эффективности и безопасности. Эффективная фармакотерапия [Ревматология. Травматология. Ортопедия] № 1, 2011.
4. Barden J., Derry S., McQuay H.J., Moore R. A. Single dose oral ketoprofen and dexketoprofen for acute postoperative pain in adults. Cochrane Database Syst Rev. 2009 Oct 7; (4).
5. Moore R. A., Barden J. Systematic review of dexketoprofen in acute and chronic pain. BMC Clin Pharmacol. 2008 Oct 31; 8: 11.
6. Hunna M, Moon J. A. A review of dexketoprofen trometamol in acute pain. Curr Med Res Opin 2019 Feb. 35 (2) 189–202.
7. Richette P, Doherty M, Pascual E, et al. 2016 updated EULAR evidence-based recommendations for the management of gout. Ann Rheum Dis. 2017 Jan; 76 (1): 29–42.
8. Chan C, Reid C, Aw T, et al. Do COX-2 inhibitors raise blood pressure more than nonselective NSAIDs and placebo? An updated meta-analysis. J. Hypertens. 2009; 27 (12): 2332–41.
9. Aljadhey H, Tu W, Hansen RA, et al. Comparative effects of nonsteroidal anti-inflammatory drugs (NSAIDs) on blood pressure in patients with hypertension. BMC Cardiovasc Disord. 2012 Oct. 24; 12: 93.
10. Т. Е. Морозова, Д. Г. Шмарова, С. М. Рыкова. Выбор нестероидных противовоспалительных препаратов у больных ревматологического профиля с сопутствующими сердечно-сосудистыми заболеваниями. Лечащий врач 2016; 7, 39.
11. Laporte J., Ibanez L., Vidal X. et al. Upper gastrointestinal bleeding associated with the use of NSAIDs. Drug Saf. 2004; 27 (6): 411–420.
12. Рациональное использование нестероидных противовоспалительных препаратов. Клинические рекомендации. Научно-практическая ревматология. 2018; 56 (прил. 1); 1–29.
13. Е.А Межеветина. Контрацепция и здоровье женщины. Гинекология 1998, № 2, 29–39.
14. Peat S. 10th World Congress of Pain 2002, San Diego, 945–P215.
Review
For citations:
Omelchenko M.Yu. Non-steroidal anti-inflammatory drugs in practice of cardiologist: choice of drug. Medical alphabet. 2020;(28):22-26. (In Russ.) https://doi.org/10.33667/2078-5631-2020-28-22-26
Views:
379
Email this article 